Is NCT03451110 results overdue?

Yes — results are overdue. Primary completion was 2018-03-23; the FDAAA-801 reporting deadline (2019-03-23) passed 2693 days ago and no results are posted on ClinicalTrials.gov.

Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects

NCT ID	NCT03451110 ↗
Sponsor	Eisai Inc. (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-03-23 (ACTUAL)
Reporting deadline	2019-03-23 (completion + 365d)
Days overdue	2693
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `61598977294623f2…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03451110. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.